We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Smith & Nephew Buys Blue Belt Technologies

By HospiMedica International staff writers
Posted on 10 Nov 2015
Smith & Nephew (London, United Kingdom) has made a bid to acquire robotic-assisted orthopedic surgery partner Blue Belt Technologies (Plymouth, MN, USA) for USD 275 million.

The two companies have been working together since July 2014, when they disclosed a partnership for the use of Blue Belt's Navio surgical system in partial knee replacements with the Smith & Nephew Journey Uni knee system. More...
In a company statement, Smith & Nephew said it expects the Navio surgical system will give it an edge in sales over the Stryker (Kalamazoo, MI, USA) Mako system, and expect the annual revenue growth to be in excess of 50% over the medium-term from a 2015 base of approximately USD 19 million.

Smith & Nephew also expect significant growth from a range of new product launches that will expand Navio into indications beyond partial knees, such as a total knee system due to launch in 2017, and a future revision knee system, a highly complex and fast-growing area that is currently not served by robotics. A bi-cruciate retaining knee arthroplasty system that could offer patients more natural motion and greater stability by preserving the anterior and posterior cruciate ligaments is also in development.

“With regard to the selling price of the Mako system compared with the Blue Belt one, the Blue Belt system is considerably lower priced. It's approximately less than half the price of the Mako system, so there's considerable advantage in relation to that,” said Julie Brown, CFO of Smith & Nephew. “This is coupled with another advantage of the system, in the sense that it's a very portable system.”

“Our experience working with Blue Belt Technologies and our customer insight has convinced us that robotics will become increasingly mainstream across orthopedic reconstruction in the foreseeable future,” said Olivier Bohuon, CEO of Smith & Nephew. “This acquisition is a compelling strategic move, with the combination of complementary products and R&D programs creating a platform from which we can shape this exciting new area of surgery. It reinforces our distinctive orthopedic reconstruction strategy, which combines cutting edge innovation, disruptive business models and a strong emerging markets platform to drive outperformance.”

“Blue Belt Technologies has redefined robotics in orthopedic surgery, establishing strong traction with customers who are attracted by the high degrees of implant placement accuracy made possible by Navio, as well as its ease of use, portability and attractive economics,” said Eric Timko, president and CEO of Blue Belt Technologies. “We are delighted to be joining with Smith & Nephew, with whom we share a passion for innovation and a mission to support healthcare professionals. Together, we will realize the many opportunities to bring the benefits of robotics-assisted surgery to more patients and new indications.”

Related Links:

Smith & Nephew
Blue Belt Technologies
Stryker



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Cervical Seal
Omni Lok
New
Complete Hip System
Taperloc Complete Hip System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.